Yaser Vezir

Yaser
Vezir

R&D Responsible
Dollvet Biyoteknoloji
Email 
w.yaser [at] dollvet.com.tr
LinkedIn 
View profile
Biography

PERSONAL STATEMENT

Professional in vaccine production, microbiology and virology, veterinary medicine  

WORK EXPERIENCE

Since November 2014- Dollvet bioteknoloji- Turkey. Responsible of Research and development as well customer technical adviser

May 2014 – October 2014, An’aam International Company for animal trading. In Burao –Somali. Responsibility, head of quarantine station and veterinary diagnostic laboratory, superstition all the quarantine procedures before exportation of animals.

2011 –April 2014 Directorate of animal health in Syria- Head of the vaccine production department.

2008-2011- Ministry of agriculture and agrarian reform, directorate of animal health- Syria. Responsible of Foot and Mouth Disease Research laboratory

200-2003- Privet veterinary clinic- Homs- Syria

EDUCATION

1996- 2000 License in Veterinary Medicine in Al Baath University – Syria

2008 Ph D in Veterinary sciences (Veterinary microbiology, virology, infectious diseases, mycology and mycotoxicology and immunology)- specialization veterinary virology. From Moscow State Academy of Veterinary Medicine and Biotechnology, Department of Virology– Russia.

TRAINING

April 2011: Training curs about Foot and Mouth Disease vaccine production in Shap institute – Ankara- Turkey.

May 2011: Training curs in the field of the production of veterinary vaccines in Pendik Institute – Istanbul- Turkey.

July 2017: Veterinary vaccines quality control in (AU-PANVAC) AU pan African veterinary vaccine institute- Ethiopia

 

August 2019: Clostridia vaccine production & control in BENTENBIOTECH – Uruguay

July 2021: Chromatography protein purification training by Cyteva- Ankara

MEETINGS &WORKSHOPS:

September 2009 Participated in the Closed Session of the Standing Technical Committee for Foot and Mouth Disease. In Slovenia

May 2010 participated in the international veterinary week in 2010 Cremona – Italy, organized by ANMVI (Associazione Nazionale Medici Veterinari Italiani)

December 2010 participated in the West Eurasia FMD Control - Roadmap 2020 –

2nd Regional meeting to review progress for Foot and Mouth Disease in Istanbul- Turkey

April 2014: participated in the West Eurasia FMD Control - Roadmap. 5th Regional meeting to review progress for Foot and Mouth Disease in Astana-Kazakhstan.

2010- Participated in validation of slaughterhouses and slaughter controlling, with a delegation for control and regulation the meat export into Syria from Poland and India in 2012.

December 2016: Attended successfully training curs in project management, organized by the Project Management Institute.

EXPERIENCE:

Recorded two patents in the Russian Federal Service of Patents in the field of virology. Under the numbers: 2372938 (13) C1 and (13) 2362585 C1 Good practical experience in laboratory diagnoses for animal diseases including bacterial as Brucellosis, Chlamydia, Mycoplasma, and viral diseases as FMD, PPR, RFV, IBR, LSD and BVDV etc. also equine diseases. Controlling Lumpy Skin Disease, Vaccine production, quality control, disease control and risk analysis. Developing E Coli vaccine against calve diarrhea as well adaptation the hyper immune serum production system. GMP management of Live attenuated viral and inactivated vaccines production laboratories. Good experience with all laboratory methods (ELIS, PCR, CFT, SNT, SDS page, western blot), virus isolation, identification, Expert in the registration documents of pharmaceutical products in many countries. Preparation the production & quality control vaccine protocol.   Production, validation control of MASTITIS, Newborn calf diarrhea vaccine containing Bovine Rota, Bovine coronaviruses strains as well Escherichia Coli strains. Adaptation the production lines for clostridial vaccines starting from the production, in process control, formulation, final product control, with optimization of largescale production Isolation, identification, and adaptation the cultivation steps of SARS COV2 virus, following by the largescale optimization of inactivated SARS COV 2 vaccine by the production in bioreactors, column chromatography purification and batch records. Isolation and identification of bovine ephemeral fever from Sanliurfa province cattle in Turkey. Wide spectrum net communication in the middle east, North Africa, and Eurasia, with good technical support, marketing and selling experience. 

LANGUAGES

Arabic, English, Turkish and Russian

Research interests

Smal Rumınants vaccines, Larg Ruminants Vaccines and poultry vaccines 

Discipline
Bacteriology Cellular biology Virology
Host species
Cats Cattle Dogs Fish Horses Poultry Small ruminants
Pathogen
BacteriaClostridia BacteriaE. coli BacteriaMycoplasma Viruses VirusesAdenovirus VirusesBovine ephemeral fever virus VirusesBovine viral diarrhoea VirusesCalicivirus VirusesCapripoxvirus VirusesCoronavirus VirusesFoot-and-mouth disease virus VirusesHerpesvirus VirusesPoxviruses VirusesRabies virus VirusesRespiratory syncytial virus VirusesRotavirus
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Field trials Pre-clinical trials